| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/ATVBAHA.107.156273 |
| P698 | PubMed publication ID | 17962622 |
| P50 | author | Andras Gruber | Q59594141 |
| Owen J T McCarty | Q87022376 | ||
| P2093 | author name string | Enrico Di Cera | |
| Erik I Tucker | |||
| Leslie A Bush-Pelc | |||
| Michelle A Berny | |||
| Tara C White | |||
| P2860 | cites work | Thrombin activation of factor XI on activated platelets requires the interaction of factor XI and platelet glycoprotein Ib alpha with thrombin anion-binding exosites I and II, respectively | Q45063820 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 329-334 | |
| P577 | publication date | 2007-10-25 | |
| P1433 | published in | Arteriosclerosis, Thrombosis, and Vascular Biology | Q4797542 |
| P1476 | title | Thrombin mutant W215A/E217A acts as a platelet GPIb antagonist | |
| P478 | volume | 28 |
| Q35317139 | Allostery in trypsin-like proteases suggests new therapeutic strategies |
| Q34350992 | Characterization of human platelet binding of recombinant T cell receptor ligand. |
| Q36819410 | Design of Factor XIII V34X activation peptides to control ability to interact with thrombin mutants |
| Q33911257 | Engineering thrombin for selective specificity toward protein C and PAR1. |
| Q92321008 | Enhancing the anticoagulant profile of meizothrombin |
| Q37374500 | Identification of coagulation factor XI as a ligand for platelet apolipoprotein E receptor 2 (ApoER2). |
| Q35200296 | Laminin promotes coagulation and thrombus formation in a factor XII-dependent manner |
| Q42030991 | Long range communication between exosites 1 and 2 modulates thrombin function |
| Q27646504 | Mechanism of the Anticoagulant Activity of Thrombin Mutant W215A/E217A |
| Q30473382 | Molecular Imaging of Activated von Willebrand Factor to Detect High-Risk Atherosclerotic Phenotype |
| Q37853216 | Proteases as therapeutics |
| Q47698131 | Protein C supports platelet binding and activation under flow: role of glycoprotein Ib and apolipoprotein E receptor 2. |
| Q37704695 | Rational Design of Protein C Activators. |
| Q92832892 | Residues W215, E217 and E192 control the allosteric E*-E equilibrium of thrombin |
| Q27667649 | Rigidification of the autolysis loop enhances Na+ binding to thrombin |
| Q33573544 | Spatial distribution of factor Xa, thrombin, and fibrin(ogen) on thrombi at venous shear |
| Q27655637 | Stabilization of the E* Form Turns Thrombin into an Anticoagulant |
| Q35067408 | The development of inflammatory joint disease is attenuated in mice expressing the anticoagulant prothrombin mutant W215A/E217A. |
| Q92907664 | The protein C activator AB002 rapidly interrupts thrombus development in baboons |
| Q36800534 | Thrombin |
| Q42535728 | Thrombomodulin is required for the antithrombotic activity of thrombin mutant W215A/E217A in a mouse model of arterial thrombosis |
| Q53061821 | Unravelling the mechanism and significance of thrombin binding to platelet glycoprotein Ib |
| Q39208821 | Utility of microfluidic devices to study the platelet-endothelium interface |
| Q35202310 | WEDGE: an anticoagulant thrombin mutant produced by autoactivation. |
Search more.